Lin SY - Search Results

1

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors.

Motzer RJ, Cooper K, Geller NL, Pfister DG, Lin SY, Bajorin D, Scher HI, Herr H, Fair W, Morse M, et al. Motzer RJ, et al. Among authors: lin sy. Cancer. 1990 Jun 1;65(11):2465-70. doi: 10.1002/1097-0142(19900601)65:11<2465::aid-cncr2820651112>3.0.co;2-7. Cancer. 1990. PMID: 1692505

2

Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease.

Scher HI, Curley T, Geller N, Engstrom C, Dershaw DD, Lin SY, Fitzpatrick K, Nisselbaum J, Schwartz M, Bezirdjian L, et al. Scher HI, et al. Among authors: lin sy. J Clin Oncol. 1990 Nov;8(11):1830-8. doi: 10.1200/JCO.1990.8.11.1830. J Clin Oncol. 1990. PMID: 1700078

3

Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features.

Toner GC, Geller NL, Lin SY, Bosl GJ. Toner GC, et al. Among authors: lin sy. Cancer. 1991 Apr 15;67(8):2049-57. doi: 10.1002/1097-0142(19910415)67:8<2049::aid-cncr2820670807>3.0.co;2-h. Cancer. 1991. PMID: 1848473

4

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection.

Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, Motzer RJ, Scher HI, Herr HW, Morse MJ, et al. Toner GC, et al. Among authors: lin sy. J Clin Oncol. 1990 Oct;8(10):1683-94. doi: 10.1200/JCO.1990.8.10.1683. J Clin Oncol. 1990. PMID: 2170590

5

Carcinoma of major salivary glands. Recent trends.

Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Spiro RH, et al. Among authors: lin sy. Arch Otolaryngol Head Neck Surg. 1989 Mar;115(3):316-21. doi: 10.1001/archotol.1989.01860270058015. Arch Otolaryngol Head Neck Surg. 1989. PMID: 2537093

6

Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a phase I multicenter trial of the AIDS Clinical Trials Group.

Paredes J, Kahn JO, Tong WP, Feldstein ML, Lin S, Bennett JM, Metroka CE, Ratner L, Krown SE. Paredes J, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1;9(2):138-44. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7749790 Clinical Trial.

7

Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors.

Motzer RJ, Gulati SC, Tong WP, Menendez-Botet C, Lyn P, Mazumdar M, Vlamis V, Lin S, Bosl GJ. Motzer RJ, et al. Cancer Res. 1993 Aug 15;53(16):3730-5. Cancer Res. 1993. PMID: 8393380 Clinical Trial.

8

Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.

Atiq OT, Kelsen DP, Shiu MH, Saltz L, Tong W, Niedzwiecki D, Trochanowski B, Lin S, Toomasi F, Brennan M. Atiq OT, et al. J Clin Oncol. 1993 Mar;11(3):425-33. doi: 10.1200/JCO.1993.11.3.425. J Clin Oncol. 1993. PMID: 8445416 Clinical Trial.

9

Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia.

Berman E, McBride M, Lin S, Menedez-Botet C, Tong W. Berman E, et al. Leukemia. 1995 Oct;9(10):1631-7. Leukemia. 1995. PMID: 7564501 Clinical Trial.

10

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD. Pinto JT, et al. Clin Cancer Res. 1996 Sep;2(9):1445-51. Clin Cancer Res. 1996. PMID: 9816319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,928 results

Search Page

Filters